JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.57B |
| 2 |
Occidental Petroleum
OXY
|
+$966M |
| 3 |
Meta Platforms (Facebook)
META
|
+$738M |
| 4 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$661M |
| 5 |
TRCO
TRIBUNE MEDIA COMPANY CLASS A
TRCO
|
+$625M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Europe ETF
VGK
|
+$1.54B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$903M |
| 3 |
KMP
KINDER MORGAN ENER PNTRS L.P.
KMP
|
+$865M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$775M |
| 5 |
Freeport-McMoran
FCX
|
+$543M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.23% |
| 2 | Financials | 13.31% |
| 3 | Healthcare | 10.98% |
| 4 | Technology | 10.39% |
| 5 | Industrials | 8.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2576
Qualys
QLYS
$6.87B
| $3.05M | ﹤0.01% |
80,823
-29,602
| -27% | -$988K |
2014 Q2
2 quarters
|
|
2577
John B. Sanfilippo & Son
JBSS
$796M
| $3.04M | ﹤0.01% |
66,725
+54,925
| +465% | +$2.15M |
2013 Q2
6 quarters
|
|
2578
Genpact
G
$5.61B
| $3.04M | ﹤0.01% |
160,303
-1,366
| -0.8% | -$24.1K |
2013 Q2
6 quarters
|
|
|
HVB
2579
DELISTED
HUDSON VY HLDG CORP
HVB
| $3.04M | ﹤0.01% |
111,742
+30,450
| +37% | +$721K |
2013 Q2
6 quarters
|
|
2580
AerCap
AER
$22.5B
| $3.03M | ﹤0.01% |
78,164
+70,941
| +982% | +$2.93M |
2014 Q2
2 quarters
|
|
|
AFT
2581
DELISTED
Apollo Senior Floating Rate Fund Inc.
AFT
| $3.03M | ﹤0.01% |
182,245
+77,859
| +75% | +$1.32M |
2013 Q4
4 quarters
|
|
2582
PUT
GoPro
GPRO
$281M
| $3.02M | ﹤0.01% |
47,800
-94,700
| -66% | -$6.98M |
2014 Q3
1 quarter
|
|
|
GPOR
2583
DELISTED
Gulfport Energy Corp.
GPOR
| $3M | ﹤0.01% |
71,994
-10,236
| -12% | -$479K |
2013 Q2
6 quarters
|
|
|
POT
2584
PUT
DELISTED
Potash Corp Of Saskatchewan
POT
| $3M | ﹤0.01% |
84,900
-19,200
| -18% | -$654K |
2014 Q3
1 quarter
|
|
2585
iShares US Healthcare ETF
IYH
$3.93B
| $2.97M | ﹤0.01% |
102,975
-71,530
| -41% | -$2.01M |
2013 Q2
6 quarters
|
|
|
MACK
2586
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $2.97M | ﹤0.01% |
33,381
-10,326
| -24% | -$752K |
2013 Q2
6 quarters
|
|
|
OTIC
2587
DELISTED
Otonomy, Inc.
OTIC
| $2.94M | ﹤0.01% |
88,314
+63,314
| +253% | +$1.7M |
2014 Q3
1 quarter
|
|
2588
3D Systems Corp
DDD
$591M
| $2.94M | ﹤0.01% |
89,296
-1,921,040
| -96% | -$69.3M |
2013 Q2
6 quarters
|
|
2589
PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund
HYS
$1.73B
| $2.91M | ﹤0.01% |
28,906
-68,524
| -70% | -$7.07M |
2013 Q2
6 quarters
|
|
|
CVA
2590
DELISTED
Covanta Holding Corporation
CVA
| $2.91M | ﹤0.01% |
132,346
-681,933
| -84% | -$15.4M |
2013 Q2
6 quarters
|
|
2591
Movado Group
MOV
$746M
| $2.91M | ﹤0.01% |
102,677
-496,311
| -83% | -$15.4M |
2013 Q2
6 quarters
|
|
2592
NewMarket
NEU
$8.5B
| $2.91M | ﹤0.01% |
7,206
-52,145
| -88% | -$20.1M |
2013 Q2
6 quarters
|
|
2593
iShares International Select Dividend ETF
IDV
$8.15B
| $2.9M | ﹤0.01% |
85,952
-5,675
| -6% | -$199K |
2013 Q2
6 quarters
|
|
2594
CALL
Kimberly-Clark
KMB
$31.7B
| $2.89M | ﹤0.01% |
25,000
+14,987
| +150% | +$1.66M |
2014 Q3
1 quarter
|
|
|
2595
PUT
Kimberly-Clark
KMB
$31.7B
| $2.89M | ﹤0.01% |
25,000
+8,938
| +56% | +$992K |
2014 Q3
1 quarter
|
|
|
BAS
2596
DELISTED
Basis Energy Services, Inc.
BAS
| $2.88M | ﹤0.01% |
722
+65
| +10% | +$410K |
2013 Q2
6 quarters
|
|
2597
Eledon Pharmaceuticals
ELDN
$203M
| $2.88M | ﹤0.01% |
1,208
-19
| -2% | -$45.1K |
2014 Q3
1 quarter
|
|
|
MWW
2598
DELISTED
Monster Worldwide Inc
MWW
| $2.87M | ﹤0.01% |
621,408
+594,354
| +2,197% | +$2.62M |
2013 Q2
6 quarters
|
|
|
MR
2599
DELISTED
MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A
MR
| $2.87M | ﹤0.01% |
108,656
-42,820
| -28% | -$1.25M |
2013 Q2
6 quarters
|
|
2600
Viavi Solutions
VIAV
$11.5B
| $2.87M | ﹤0.01% |
367,076
-9,217
| -2% | -$68.7K |
2013 Q2
6 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2014 Portfolio in Review
As of Q4 2014, JP Morgan Chase held 4,595 positions worth $437B, up 3.7% from $422B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q4 2014 filing shows 424 new, 1,620 increased, 1,864 reduced and 391 closed positions. Its largest new stake was TRIBUNE MEDIA COMPANY CLASS A: 10,171,721 shares worth $608M. The largest sale was Vanguard FTSE Europe ETF, an estimated $1.54B.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q4 2014 buy was TRIBUNE MEDIA COMPANY CLASS A: 10,171,721 shares worth $608M.
- JP Morgan Chase added most to State Street SPDR S&P 500 ETF Trust in Q4 2014, an estimated $2.57B increase.
- JP Morgan Chase's biggest Q4 2014 reduction was Vanguard FTSE Europe ETF, cutting an estimated $1.54B.
- JP Morgan Chase fully exited KINDER MORGAN ENER PNTRS L.P. in Q4 2014, selling an estimated $865M.
- JP Morgan Chase's ten largest holdings make up 16% of its $437B portfolio in Q4 2014.
- JP Morgan Chase opened 424 new positions and closed 391 in Q4 2014.
- JP Morgan Chase's portfolio value rose 3.7% quarter-over-quarter to $437B.
Based on JP Morgan Chase's 13F filing for Q4 2014, filed 13 Feb 2015.